TY - JOUR
T1 - The preventive treatment of migraine
AU - Bigal, Marcelo E.
AU - Lipton, Richard B.
PY - 2006/7/1
Y1 - 2006/7/1
N2 - BACKGROUND: Migraine is a common, chronic, and disabling disorder. The treatment of migraine includes a combination of nonpharmacologic and pharmacologic techniques. Pharmacologic approaches are subdivided in preventive therapies and acute care. REVIEW SUMMARY: In this review article, we review the current approaches to the preventive treatment of migraine. Preventive treatment should be initiated in those with frequent or disabling headaches. The goals include (1) reducing attack frequency, intensity, and duration; (2) minimizing headache-related disability; (3) improving health-related quality of life; (4) avoiding headache escalation and medication misuse. In this article, we also discuss the principles of migraine prevention, as well as drugs available for this goal. We divide preventive medications on those of common use, nutraceutical compounds, and medications less frequently used. We close by briefly discussing some in-development potential preventive drugs. CONCLUSION: Preventive therapies are well suitable for migraineurs with attack-related disability despite appropriate acute care.
AB - BACKGROUND: Migraine is a common, chronic, and disabling disorder. The treatment of migraine includes a combination of nonpharmacologic and pharmacologic techniques. Pharmacologic approaches are subdivided in preventive therapies and acute care. REVIEW SUMMARY: In this review article, we review the current approaches to the preventive treatment of migraine. Preventive treatment should be initiated in those with frequent or disabling headaches. The goals include (1) reducing attack frequency, intensity, and duration; (2) minimizing headache-related disability; (3) improving health-related quality of life; (4) avoiding headache escalation and medication misuse. In this article, we also discuss the principles of migraine prevention, as well as drugs available for this goal. We divide preventive medications on those of common use, nutraceutical compounds, and medications less frequently used. We close by briefly discussing some in-development potential preventive drugs. CONCLUSION: Preventive therapies are well suitable for migraineurs with attack-related disability despite appropriate acute care.
KW - Migraine prevention
KW - Preventive treatment
UR - http://www.scopus.com/inward/record.url?scp=33746568433&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746568433&partnerID=8YFLogxK
U2 - 10.1097/01.nrl.0000219666.65101.a9
DO - 10.1097/01.nrl.0000219666.65101.a9
M3 - Review article
C2 - 16832239
AN - SCOPUS:33746568433
SN - 1074-7931
VL - 12
SP - 204
EP - 213
JO - Neurologist
JF - Neurologist
IS - 4
ER -